$10.50
-0.78-6.91%
Last update: Nov 11, 9:21 AM
Gossamer Bio Inc
GOSSNASDAQ
Gossamer Bio rose 311.0% from $2.59 to $10.65, ahead of the S&P 500's +9.8%. Its worst day was Feb 23 (−80.1%), and its low came Jul 24 at $0.14.
Nov 11, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.21 missed the $-0.20 estimate on $13.8M revenue (est. $7.6M).
−8.0% · S&P 500 −1.4%
EPS of $-0.20 missed the $-0.17 estimate on $17.0M revenue (est. $4.9M).
Story events cover the past 12 months · Times ET
−43.3% · S&P 500 −0.1%
Gossamer Bio closed at its lowest level of the year, 94.7% below where the year started.
−4.6% · S&P 500 +0.1%
EPS of $-0.08 beat the $-0.12 estimate on $9.2M revenue (est. $3.6M).
−9.5% · S&P 500 −0.2%
Gossamer Bio closed at its highest level of the year, 361.0% above where the year started.
+8.9% · S&P 500 +0.9%
Where it ended: a close of $10.64 on Nov 9, 2026.
Nothing in the past 12 months.
All GOSS dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GOSS and SPY from Benzinga historical bars. Not investment advice.
